Fig. 2From: Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomasOverall survival (OS) and progression-free survival (PFS) after stereotactic brachytherapy (SBT) of all 106 patientsBack to article page